RA CD4+ T-cells and fibroblast-like synoviocytes (RA-FLS) were treated with BMSC, exosomes, or JKAP-modified exosomes ± AKT/ERK inhibitors. This evidence concerns the gene CD4 and rheumatoid arthritis.